Skip to main content

Advertisement

Log in

Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Interstitial cystitis is a multifaceted medical condition consisting of pelvic pain, urgency, and frequency. Can sacral neuromodulation be successfully utilized for the medium term of ≥6 years in interstitial cystitis patients for whom standard drug therapies have failed?

Methods

In our observational, retrospective, case-controlled review (January 2002–March 2004), we sought to discern whether neuromodulation could be successfully implemented with acceptable morbidity rates in interstitial cystitis patients. Thirty-four female patients underwent stage 1 and 2 InterStim placements under a general anesthetic. Simple means and medians were analyzed.

Results

Mean pre-op/post-op pelvic pain and urgency/frequency scores were 21.61 ± 8.6/9.22 ± 6.6 (p < 0.01), and mean pre-op/post-op visual analog pain scale (VAPS) were 6.5 ± 2.9/2.4 ± 1.1 (p < 0.01). Median age was 41 ± 14.8 years with a mean follow-up of 86 ± 9.8 months.

Conclusions

With a minimum 6-year follow-up we determined that sacral neuromodulation provides adequate improvement for the symptoms of recalcitrant interstitial cystitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wein AJ, Hanno PM, Gillenwater JY (1990) Interstitial cystitis: an introduction to the problem. In: Hanno PM, Staskin DR, Krane RJ et al (eds) Interstitial cystitis. Springer-Verlag, New York, pp 3–15

    Google Scholar 

  2. Powell CR, Kreder KJ (2010) Long-term outcomes of urgency frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 183:173–176

    Article  PubMed  Google Scholar 

  3. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes TA, Calhoun EA (2008) Case-control study of medical co-morbidities in women with interstitial cystitis. J Urol 179:2222–2225

    Article  PubMed  Google Scholar 

  4. Mayson BE, Teichman JM (2009) The relationship between sexual abuse and interstitial cystitis/painful bladder syndrome. Curr Urol Rep 10(6):441–447

    Article  PubMed  Google Scholar 

  5. Burks FN, Diokno AC, Lajiness MJ, Ibrahom IA, Peters KM (2008) Sacral neuromodulation reprogramming: is it an office burden? Int Urogynecol J Pelvic Floor Dysfunct 19(8):1137–1140

    Article  PubMed  Google Scholar 

  6. Dell JR, Butrick CW (2006) Multimodal therapy for painful bladder syndrome/interstitial cystitis. J Reprod Med 51:253–260

    PubMed  Google Scholar 

  7. Marinkovic SP, Moldwin R, Gillen LM, Stanton SL (2009) The management of interstitial cystitis/painful bladder syndrome in women. BMJ 339:2707–2711

    Article  Google Scholar 

  8. Amrute KV, Moldwin RM (2007) Pharmacotherapy of interstitial cystitis in women. Womens Health 3(1):63–72

    CAS  Google Scholar 

  9. Rofeim O, Hom D, Freid RM, Moldwin RM (2001) Use of neodymium:YAG laser for interstitial cystitis. A prospective study. J Urol 166(1):134–136

    Article  PubMed  CAS  Google Scholar 

  10. Payne RA, O’Connor RC, Kressin M, Guralnick ML (2009) Endoscopic ablation of Hunner's lesions in interstitial cystitis patients. Can Urol Assoc J 3(6):473–477

    PubMed  Google Scholar 

  11. Kochakarn W, Lertsithichai P, Pummangura W (2007) Bladder substitution by ileal neobladder for recalcitrant interstitial cystitis. Int Braz J Urol 33(4):486–492

    Article  PubMed  Google Scholar 

  12. Peters KM, Killinger KA, Boguslawski BM, Boura JA (2009) Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn PMID 19787710 (in press)

  13. Kohli N, Rosenblatt PL (2002) Neuromodulation techniques for the treatment of overactive bladder. Clin Obstet Gynecol 45(1):218–232

    Article  PubMed  Google Scholar 

  14. Comiter CV (2003) Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 169(4):1369–1373

    Article  PubMed  Google Scholar 

  15. Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV (2008) Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct 19(4):553–557

    Article  PubMed  Google Scholar 

  16. Chuang YC, Lee WC, Chiang PH (2009) Intravesical liposome versus oral pentosan polysulfate sodium for interstitial cystitis/painful bladder syndrome. J Urol 182(4):1393–1400

    Article  PubMed  CAS  Google Scholar 

  17. Van Ophoven A, Hertle L (2005) Long-term results of amitriptyline treatment of interstitial cystitis. J Urol 174(5):1837–1840

    Article  PubMed  Google Scholar 

  18. Nishijima S, Sugaya K, Yamada T, Miyazato M, Ogawa Y (2006) Efficacy of tricyclic antidepressants is associated with adrenoceptor genotype in patients with interstitial cystitis. Biomed Res 27(4):163–167

    Article  PubMed  CAS  Google Scholar 

  19. Sasaki K, Smith CP, Chuang YC, Lee JY, Kim JC, Chancellor MB (2001) Oral gabapentin (neurontin) treatment of refractory genitourinary tract pain. Tech Urol 7(1):47–49

    PubMed  CAS  Google Scholar 

  20. Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, Hardy C, Landis JR, Peters K, Theoharides TC, Warren J, Wein AJ, Steers W, Kusek JW, Nyberg LM (2003) A pilot clinical trial of oral pentosan polysulfate and hydroxyzine in patients with interstitial cystitis. J Urol 170(3):810–815

    Article  PubMed  CAS  Google Scholar 

  21. Dawson TE, Jamison J (2007) Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database System Rev 17(4):CD006113

    Google Scholar 

  22. Parsons CL, Dell J, Stanford EJ, Bullen M, Kahn BS, Wawell T, Koziol JA (2002) Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified with new symptom questionnaire and intravesical potassium sensitivity. Urology 60(4):573–578

    Article  PubMed  Google Scholar 

  23. Brewer ME, White WM, Klein FA, Klein LM, Waters WB (2007) Validity of pelvic pain, urgency and frequency questionnaire in patients with interstitial cystitis syndrome. Urology 70(4):646–649

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Serge P. Marinkovic.

Additional information

We have not asked for nor received any funds from the federal, state, or local governments or universities.

We consign our rights to this paper to the International Urogynecology Journal and have not submitted this paper to any other journal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marinkovic, S.P., Gillen, L.M. & Marinkovic, C.M. Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation. Int Urogynecol J 22, 407–412 (2011). https://doi.org/10.1007/s00192-010-1235-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-010-1235-9

Keywords

Navigation